Anthony Coles is chairman and CEO of Onyx Pharmaceuticals, a global biopharmaceutical company engaged in the development and commercialization of innovative therapies for cancer patients. Before joining Onyx in 2008, Coles was president, CEO, and a member of the board of NPS Pharmaceuticals. Trained as a cardiologist and internist, Coles’ career in the pharmaceutical industry includes executive positions at Vertex Pharmaceuticals and Bristol-Myers Squibb. Prior to that, he served as vice president of the Hypertension and Heart Failure Business Group at Merck & Co.